Metformin Hydrochloride Sustained Release Tablet

Metformin Hydrochloride Sustained Release Tablet

In order to reduce the occurrence of gastrointestinal complications and to use the minimum dose of drugs to control their blood glucose, it should be taken from small doses and gradually increase the dose.

Product Introduction
Ingredients

 

The main ingredient is metformin hydrochloride.

 

product-800-533

 

character

 

It is a white capsule shaped tablet with the words "C8" engraved on one side and "500" engraved on the other side.

 

Indication

 

1. As a separate treatment, it is recommended to combine diet and exercise therapy to control the blood sugar of type 2 diabetes.

2. This product can be used in combination with sulfonylurea drugs or insulin to control adult blood sugar.

 

Specifications

 

0.5g

 

usage and dosage

 

The whole tablet must be swallowed and must not be crushed or taken after chewing.

In order to reduce the occurrence of gastrointestinal complications and to use the minimum dose of drugs to control their blood glucose, it should be taken from small doses and gradually increase the dose.

During the start of treatment and dose adjustment (see recommended medication schedule), determining fasting glucose can be used to determine the treatment response of the product and to determine the minimum effective dose for the patient. Thereafter, HbA 1 c should be measured at March intervals. Whether alone or in combination with sulfonylurea and insulin, the goal of treatment is to use the lowest effective dose to reduce fasting glucose and HbA 1 c levels to normal or near normal levels.

 

Contraindication

 

Severe renal failure (eGFR<45mL/min/1.73m2); Acute conditions that may affect renal function, such as dehydration, severe infection, shock; Diseases that can cause tissue hypoxia (especially acute disease or deterioration of chronic diseases), such as decompensated heart failure, respiratory failure, recent onset myocardial infarction and shock; Severe infection and trauma, major surgical operations, clinical hypotension and hypoxia; Known allergy to metformin hydrochloride and any ingredient in this product; Any acute metabolic acidosis, including lactic acidosis, diabetic ketoacidosis; Diabetic prodromal coma period

 

pharmacological action

 

Metformin reduces hepatic glucose production, suppresses intestinal glucose absorption, and increases the uptake and utilization of glucose in peripheral tissues, and may increase insulin sensitivity by increasing the uptake and utilization of peripheral glucose.

 

Storage

 

Seal preservation.

 

Hot Tags: metformin hydrochloride sustained release tablet, China metformin hydrochloride sustained release tablet manufacturers, suppliers, antidiabetic aerosol, glucose-lowering intravenous

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag